Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Dmochowski

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Neurourology and Urodynamics|August 23, 2018
How can we develop a more clinically useful and robust algorithm for diagnosing and treating nocturia? ICI-RS 2017Karel Everaert, François Hervé, Wendy Bower, et al.
BJU International|February 1, 2017
Positive outcomes with first onabotulinumtoxinA treatment persist in the long term with repeat treatments in patients with neurogenic detrusor overactivityPierre Denys, Roger Dmochowski, Philip Aliotta, et al.
Urology|August 20, 2013
The impact of OAB on physical activity in the United States: results from OAB-POLLKarin S Coyne, Chris C Sexton, J Quentin Clemens, et al.
Urology|July 4, 2012
Impact of overactive bladder on work productivityKarin S Coyne, Chris C Sexton, Christine L Thompson, et al.
The Journal of Urology|November 8, 2017
An Evidence-Based Protocol for Antibiotic Use Prior to Cystoscopy Decreases Antibiotic Use without Impacting Post-Procedural Symptomatic Urinary Tract Infection RatesJustin R Gregg, Rohan G Bhalla, J Paul Cook, et al.
Neurourology and Urodynamics|June 11, 2011
Nocturia: new directionsJeffrey P Weiss, Alan J Wein, Philip van Kerrebroeck, et al.
The Journal of Urology|October 19, 2010
Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trialRoger Dmochowski, Christopher Chapple, Victor W Nitti, et al.
Neurourology and Urodynamics|May 1, 2010
Nocturia research: current status and future perspectivesPhilip E V Van Kerrebroeck, Roger Dmochowski, Mary P FitzGerald, et al.
European Urology|October 9, 2018
Systematic Review of Combination Drug Therapy for Non-neurogenic Lower Urinary Tract SymptomsMaurizio Serati, Karl-Erik Andersson, Roger Dmochowski, et al.
Urology|January 8, 2013
Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysisMichael Kennelly, Roger Dmochowski, Karen Ethans, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Neurourology and Urodynamics|August 23, 2018
How can we develop a more clinically useful and robust algorithm for diagnosing and treating nocturia? ICI-RS 2017Karel Everaert, François Hervé, Wendy Bower, et al.
BJU International|February 1, 2017
Positive outcomes with first onabotulinumtoxinA treatment persist in the long term with repeat treatments in patients with neurogenic detrusor overactivityPierre Denys, Roger Dmochowski, Philip Aliotta, et al.
Urology|August 20, 2013
The impact of OAB on physical activity in the United States: results from OAB-POLLKarin S Coyne, Chris C Sexton, J Quentin Clemens, et al.
Urology|July 4, 2012
Impact of overactive bladder on work productivityKarin S Coyne, Chris C Sexton, Christine L Thompson, et al.
The Journal of Urology|November 8, 2017
An Evidence-Based Protocol for Antibiotic Use Prior to Cystoscopy Decreases Antibiotic Use without Impacting Post-Procedural Symptomatic Urinary Tract Infection RatesJustin R Gregg, Rohan G Bhalla, J Paul Cook, et al.
Neurourology and Urodynamics|June 11, 2011
Nocturia: new directionsJeffrey P Weiss, Alan J Wein, Philip van Kerrebroeck, et al.
The Journal of Urology|October 19, 2010
Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trialRoger Dmochowski, Christopher Chapple, Victor W Nitti, et al.
Neurourology and Urodynamics|May 1, 2010
Nocturia research: current status and future perspectivesPhilip E V Van Kerrebroeck, Roger Dmochowski, Mary P FitzGerald, et al.
European Urology|October 9, 2018
Systematic Review of Combination Drug Therapy for Non-neurogenic Lower Urinary Tract SymptomsMaurizio Serati, Karl-Erik Andersson, Roger Dmochowski, et al.
Urology|January 8, 2013
Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysisMichael Kennelly, Roger Dmochowski, Karen Ethans, et al.
Pageof 19